Clinical Trials Directory

Trials / Completed

CompletedNCT01504672

An Intervention Study to Reduce Drug-related Problems and Readmissions Among Old People With Dementia

A Randomized Controlled Pharmacist Intervention Study to Reduce Drug-related Problems and Readmissions Among Old People With Dementia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
460 (actual)
Sponsor
Umeå University · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

The aim of this randomized controlled study is to investigate if medication reviews performed by a clinical pharmacist as part of a ward team can reduce drug related problems and reduce readmissions to hospital among elderly patients (≥65 years) with dementia and cognitive failure. Four hundred and sixty patients will be recruited and randomized to control (usual care) and intervention group (enhanced service in which a pharmacist is part of the health care team). Six months after the last patient of the 460 has been discharged the study will be closed. Data about the number of readmissions and visits to the emergency room will be collected during the six-month follow-up and also, the costs associated with each visit or admission. Time until institutionalization will be compared between intervention group and control group.

Conditions

Interventions

TypeNameDescription
OTHERMedication reviewIn the intervention, the pharmacist will evaluate: * Is there an indication for the drug? * Has the drug desired effect? * Is the dose correct and dosing scheme correct? * Side effects, contraindications, inappropriate drugs * Interactions * Treatment time * Cost effectiveness * Adherence to recommendation list * Problems with handling the drugs (for example crushing of the tablets) * Untreated indication * Double medications * Administration of drugs

Timeline

Start date
2012-01-01
Primary completion
2015-06-01
Completion
2015-08-01
First posted
2012-01-05
Last updated
2021-11-09
Results posted
2021-11-09

Locations

2 sites across 1 country: Sweden

Source: ClinicalTrials.gov record NCT01504672. Inclusion in this directory is not an endorsement.